Analyst Research Report Snapshot

Title:

OXFORD BIOMEDICA - CLINICAL TRIALS SET TO RESUME RECRUITMENT

Price:

$10.00

Provider:

Edison Investment Research

Date:

17 Oct 2013

Pages:

3

Type:

AcrobatPDF

Companies referenced:

OXB.L

Available for Immediate Download
Summary:

Regulatory agencies have given Oxford BioMedica the go-ahead to resume patient recruitment into the ocular clinical trials (including RetinoStat). A rapid resumption was critical since Sanofi’s decision on whether to opt-in for RetinoStat will define the company’s outlook. The cash runway currently extends to Q214. Our valuation is unchanged at £60.1m.

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.